1. Variant Profiling of Candidate Genes in Pancreatic Ductal Adenocarcinoma
   Jiaqi Huang et al, 2015, Clinical Chemistry CrossRef
2. Biomarkers in Early-Stage Non–Small-Cell Lung Cancer: Current Concepts and Future Directions
   Mauricio Burotto et al, 2014, Journal of Thoracic Oncology CrossRef
3. Structural differences between valine-12 and aspartate-12 Ras proteins may modify carcinoma aggression
   Fahd Al-Mulla et al, 1999, The Journal of Pathology CrossRef
4. Human Aldo-Keto Reductases and the Metabolic Activation of Polycyclic Aromatic Hydrocarbons
   Trevor M. Penning, 2014, Chemical Research in Toxicology CrossRef
5. G12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumab
   Ondrej Fiala et al, 2016, Tumor Biology CrossRef
6. Differences in in vitro invasive capacity induced by differences in Ki‐Ras protein mutations
   Fahd Al‐Mulla et al, 2001, The Journal of Pathology CrossRef
7. Genetic Abnormalities and Microsatellite Instability in Colorectal Cancer
   Pilar Iniesta et al, 1998, Cancer Detection Prevention CrossRef
8. Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer
   Takeshi Ogura et al, 2013, Journal of Gastroenterology CrossRef
9. Targeting non-small cell lung cancer: driver mutation beyond epidermal growth factor mutation and anaplastic lymphoma kinase fusion
   Quincy S. Chu, 2020, Therapeutic Advances in Medical Oncology CrossRef
10. Targeting Novel but Less Common Driver Mutations and Chromosomal Translocations in Advanced Non-Small Cell Lung Cancer
    Alia Daoud et al, 2017, Frontiers in Oncology CrossRef
11. Differences in gynecologic tumor development in Amhr2-Cre mice with KRASG12D or KRASG12V mutations
    Eucharist H. S. Kun et al, 2020, Scientific Reports CrossRef